SCM
GH icon

Suvretta Capital Management’s Guardant Health GH Stock Holding History

Suvretta Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-561,690
Closed -$85.7M – 126
2021
Q1 		$85.7M Sell
561,690
-47,912
-8% -$7.24M 1.27% 34
2020
Q4 		$78.6M Buy
609,602
+158,882
+35% +$18.3M 1.12% 35
2020
Q3 		$50.4M Buy
+450,720
New +$41.2M 0.91% 40

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Suvretta Capital Management's GH Position: Q2 2021 in Review

Suvretta Capital Management sold out of Guardant Health (GH) in Q2 2021, closing a stake of 561,690 shares — an estimated $85.7M sold.

Suvretta Capital Management first reported a position in GH in Q3 2020 and held it in 3 quarters. The position peaked at $85.7M in Q1 2021. 416 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • Suvretta Capital Management reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
  • Suvretta Capital Management sold 561,690 Guardant Health shares in Q2 2021, an estimated $85.7M.
  • Suvretta Capital Management first reported a position in Guardant Health in Q3 2020 and held it in 3 quarters.
  • Suvretta Capital Management's Guardant Health position peaked at $85.7M in Q1 2021.
  • 416 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Suvretta Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.